<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11861567</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.1115</article-id><article-id pub-id-type="other">EPV0404</article-id><article-id pub-id-type="pii">S0924933824011155</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Breath Gas Markers in Depression and Their Relationship with Brain Metabolism</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Keskin Gokcelli</surname><given-names>D.</given-names></name><xref rid="aff2511" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor0971" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Itzhacki Sitton</surname><given-names>J.</given-names></name><xref rid="aff2511" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kesik</surname><given-names>J.</given-names></name><xref rid="aff2511" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Henning</surname><given-names>D. H.</given-names></name><xref rid="aff2511" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Farrher</surname><given-names>E.</given-names></name><xref rid="aff2512" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Shah</surname><given-names>N. J.</given-names></name><xref rid="aff2512" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff2512" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff2513" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff2514" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Frodl</surname><given-names>T.</given-names></name><xref rid="aff2511" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="aff2511"><sup>1</sup>Department of Psychiatry, <institution>RWTH Aachen University</institution>, <city>Aachen</city></aff><aff id="aff2512"><sup>2</sup><institution>Institute of Neuroscience and Medicine 4, Forschungszentrum J&#x000fc;lich, INM-4</institution>, <country>J&#x000fc;lich</country></aff><aff id="aff2513"><sup>3</sup>Department of Neurology</aff><aff id="aff2514"><sup>4</sup>JARA &#x02013; BRAIN &#x02013; Translational Medicine, <institution>RWTH Aachen University</institution>, <city>Aachen</city>, <country>Germany</country></aff><author-notes><corresp id="cor0971"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="1090">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S537</fpage><lpage>S537</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824011155a.pdf"/><abstract><sec id="sec5838"><title>Introduction</title><p>Dysfunctional changes in the glutamatergic system play an important role in the pathophysiology of depression. Glutamate regulates various neuronal function, such as nerve migration, excitability, plasticity, as well as long-term potentiation and long-term synaptic depression. Failures in this process might cause emotional/cognitive changes associated with stress-induced depressive symptoms, a part of our current understanding of the pathophysiology of depression. These changes might be related to deviations in biochemical blood parameters, but also to volatile organic compounds (VOCs) measured in breath.</p></sec><sec id="sec5839"><title>Objectives</title><p>1) To replicate our previous finding that concentration of volatile organic compounds in expiratory breath gas and metabolites derived from MR spectroscopy distinguish unmedicated depressed patients from healthy participants, (2) to determine whether the amount of these VOCs is associated with severity of depression and anxiety, and (3) to correlate breath-VOC-content with glutamatergic neurotransmission and energy metabolism derived from MR spectroscopy.</p></sec><sec id="sec5840"><title>Methods</title><p>25 antidepressant-free patients with major depression according to DSM V (18-65 years of age) are recruited from our out- and inpatient clinics. The controls will consist of 25 healthy age-and-sex-matched participants. Breath gas analyses will be carried out at awakening, and 30 and 60 minutes thereafter, and at 5pm using PTR-TOF-MS with direct on time measurement through a special sampler. A 7 Tesla Siemens Terra MRI scanner will be used to undertake spectroscopic measurements. Concentrations of glutamate and &#x003b2;-hydroxybutyrate levels in the pregenual and dorsal anterior cingulate gyrus will subsequently be assessed.</p></sec><sec id="sec5841"><title>Results</title><p>Statistical analysis for differences between groups corrected for multiple measurements will be carried out. Concentration of VOCs will be correlated with brain metabolism and severity of symptoms.</p></sec><sec id="sec5842"><title>Conclusions</title><p>VOCs in breath are proposed to be an efficient and non-invasive marker for depression-related biochemical changes related to disease severity, and eventually useful for personalized treatment planning.</p></sec><sec id="sec5843"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>